Table 3 Univariate and multivariate Cox proportional hazards regression analyses for progression free survival of uterine sarcoma patients (n =112)

Histological types

<0.001

<0.001

 AS(N=10)

1 (referent)

1 (referent)

 ULMS(N=41)

14.062(1.623-121.837)

0.016

12.848(1.711-96.487)

0.013

 LG-ESS(N=43)

2.727(0.307-24,217)

0.368

3.476(0.438-27.594)

0.239

 HG-ESS(N=13)

108.000(5.922-1969.539)

0.002

24.223(3.039-193.068)

0.003

 UUS(N=5)

36.000(1.772-731.562)

0.020

40.268(4.307-376.520)

0.001

FIGO stage

 Stage I

1 (referent)

1 (referent)

 Stage II-IV

3.300(1.077-10.114)

0.037

3.031(1.524-6.029)

0.002

Lymphadenectomy

 Yes

1 (referent)

 No

0.939(0.444-1.986)

0.869

Initial surgery

 Laparotomy

1 (referent)

 Laparoscopy

1.604(0.746-3.451)

0.227

Ovariectomy

 Yes

1 (referent)

 No

1.375(0.531-3.562)

0.512

Age(years)

 ≤50

1 (referent)

 >50

1.852 (10.862-7.255)

0.114

Size

 ≤7.5

1 (referent)

1 (referent)

 >7.5

1.998(0.926-4.312)

0.078

2.100(1.136-3.881)

0.018

Menstrual status

 Premenopausal

1 (referent)

 Postmenopausal

2.743 (1.199-6.272)

0.017

NLR

 ≤2.14

1 (referent)

1 (referent)

 >2.14

2.7271(1.199-6.201)

0.017

1.884(0.938-3.625)

0.076

PLR

 ≤128.5

1 (referent)

 >128.5

3.419 (1.369-8.541)

0.009